In vitro activity of therapeutic antibodies against sars-cov-2 omicron ba.1, ba.2 and ba.5

HIGHLIGHTS

  • who: Franck Touret from the Unité Des Virus Émergents (UVE: Aix-Marseille University have published the article: In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5, in the Journal: Scientific Reports Scientific Reports of 19/07/2022

SUMMARY

    | 1 Vol.:(0123456789) 18.7 decrease in neutralization activity when compared to B.1, ~ 2.7 compared to BA.1 and ~ 1.9 to BA.2. This loss of activity have been recently reported using neutralization with BA.4/BA.5 spike pseudo-virus20. The neutralising . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?